Milestone fees Milestone Events Milestone Fees. 1. Completion of Commercialization Plan for use of Licensed Product or Licensed Service for early diagnosis of colon cancer. ***
Milestone fees Milestone Events Milestone Fees. 1. Completion of Commercialization Plan for use of Licensed Product or Licensed Service for early diagnosis of prostate cancer. ***
Milestone fees Milestone Events Milestone Fees. 1. Completion of Commercialization Plan for use of Licensed Product or Licensed Service for early diagnosis of ovarian cancer. ***
Milestone fees Milestone Events Milestone Fees. 1. Enter into a Sponsored Research Agreement (SRA) with Licensor with Xx. Xxxxxx Xxx as the principal investigator for *** cash *** as funding for the SRA
Milestone fees Milestone Events Milestone Fees. 1. Completion of Commercialization Plan for use of Licensed Product or Licensed Service for early diagnosis of lung cancer. ***
Milestone fees Milestone Events Milestone Fees. IND Approval on first indication of Licensed Product $50,000 Submission of final Phase II report for first Licensed Product (FDA or foreign equivalent) $100,000 Submission of final Phase III report for first Licensed Product (FDA or foreign equivalent) $250,000 Regulatory approval for first Licensed Product (FDA or foreign equivalent) $500,000 Regulatory approval for second Licensed Product or second indication of first Licensed Product (FDA or foreign equivalent) $500,000
Milestone fees Milestone Events Milestone Fees. Milestone 1: Submit report to Licensor for non-clinical immunogenicity studies in animal models [***]
Milestone fees Milestone Events Milestone Fees. 1. Submit IND (or foreign equivalent) on a first indication for a Licensed Product $100,000
Milestone fees Milestone Events Milestone Fees. All Milestones None
Milestone fees Milestone Events Milestone Fees. IND Approval on first indication of Licensed Product. $50,000 (paid) Submit IND (or foreign equivalent) on a first indication for a thin film freezing vaccine Licensed Product $50,000 Enroll first patient in Phase II clinical trial for first Licensed Product (FDA or foreign equivalent). $100,000 Enroll first patient in a Phase II clinical trial for a TFF-Vaccine Licensed Product (FDA or foreign equivalent) $100,000 Enroll first patient in Phase III clinical trial for first Licensed Product (FDA or foreign equivalent). $250,000 Enroll first patient in Phase III clinical trial for a thin film freezing vaccine Licensed Product (FDA or foreign equivalent). $250,000 Regulatory approval for a thin film freezing vaccine Licensed Product (FDA or foreign equivalent). $250,000 Regulatory approval for first Licensed Product (FDA or foreign equivalent). $500,000 Regulatory approval for second Licensed Product or second indication of first Licensed Product (FDA or foreign equivalent). $500,000
